Ross Holmes

Ross Holmes
Professor

Positions

Year	Title	Altmetric
2018	Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria 2018
2018	Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line 2018
2017	The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5 2017
2017	Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass 2017
2017	An investigational RNAi therapeutic targeting glycolate oxidase reduces oxalate production in models of primary hyperoxaluria 2017
2016	RNA interference in the treatment of renal stone disease: Current status and future potentials 2016
2016	Ascorbic acid intake and oxalate synthesis 2016
2016	Monocyte Mitochondrial Function in Calcium Oxalate Stone Formers 2016
2016	Effects of alanine: Glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay 2016
2016	Oxalate Concentrations in Human Gastrointestinal Fluid 2016
2016	Molecular Modeling of the Structural and Dynamical Changes in Calcium Channel TRPV5 Induced by the African-Specific A563T Variation 2016
2016	Lowering urinary oxalate excretion to decrease calcium oxalate stone disease 2016
2016	Metabolism of ¹³C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase 2016
2016	Oxalate formation from glyoxal in erythrocytes 2016
2015	Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3 2015
2015	Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria 2015
2015	A mutation creating an out-of-frame alternative translation initiation site in the GRHPR 5′UTR causing primary hyperoxaluria type II 2015
2012	Hydroxyproline metabolism in mouse models of primary hyperoxaluria 2012
2012	Metabolism of [ ¹³C 5]hydroxyproline in vitro and in vivo: Implications for primary hyperoxaluria 2012
2012	The association of cardiovascular disease and metabolic syndrome with nephrolithiasis 2012
2012	Multibacterial growth from a surgical renal stone culture: a case report and literature review. 2012
2011	Variability in urinary oxalate measurements between six international laboratories 2011
2011	Difficulties with access in percutaneous renal surgery 2011
2011	Re: Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers 2011
2011	Impact of dietary calcium and oxalate, and oxalobacter formigenes colonization on urinary oxalate excretion 2011
2011	Metabolism of primed, constant infusions of [1,2-¹³C 2] glycine and [1-¹³C1] phenylalanine to urinary oxalate 2011
2011	Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers 2011
2006	Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2 2006
2005	Genetic and dietary factors in urinary citrate excretion 2005
2005	Mitochondrial hydroxyproline metabolism: Implications for primary hyperoxaluria 2005
2005	Dietary oxalate loads and renal oxalate handling 2005
2004	Glycolate and glyoxylate metabolism in HepG2 cells 2004
2004	The impact of dietary oxalate on kidney stone formation 2004
2001	(L)-2-oxothiazolidine-4-carboxylate in the treatment of primary hyperoxaluria type 1 2001
2001	Contribution of dietary oxalate to urinary oxalate excretion 2001
2000	Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2) 2000
2000	Role of diet in the therapy of urolithiasis 2000
1997	Pathways of hepatic oxalate synthesis and their regulation 1997
1997	Genes in idiopathic calcium oxalate stone disease 1997
1997	Pathways of hepatic oxalate synthesis and their regulation. 1997
1997	The effects of (L)-2-oxothiazolidine-4-carboxylate on urinary oxalate excretion 1997
1996	Re: Family pattern of idiopathic hypercalciuria and its subtypes 1996
1995	Dietary oxalate and its intestinal absorption 1995
1995	Glucagon increases urinary oxalate excretion in the guinea pig. 1995
1995	Genetic Factors in Calcium Oxalate Stone Disease 1995
1995	Glucagon increases urinary oxalate excretion in the guinea pig 1995
1995	Measurement of urinary oxalate and citrate by capillary electrophoresis and indirect ultraviolet absorbance 1995
1993	The absence of glyxylate cycle enzymes in rodent and embryonic chick liver 1993
1993	Relationship of protein intake to urinary oxalate and glycolate excretion 1993
1992	Recent developments in assays for taurine, hypotaurine and some metabolic precursors 1992
1992	Tetrodotoxin protects against acute ischemic renal failure in the rat 1992
1989	Selective elevation of urinary enzyme levels after extracorporeal shock wave lithotripsy 1989
1987	Failure of leukotriene B4 to translocate calcium across phosphatidylcholine membranes 1987

Year

Title

Altmetric

2018

Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria 2018

2018

Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line 2018

2017

The L530R variation associated with recurrent kidney stones impairs the structure and function of TRPV5 2017

2017

Steatorrhea and Hyperoxaluria in Severely Obese Patients Before and After Roux-en-Y Gastric Bypass 2017

2017